Table 2 EQuIP-GP Trial timeline
Task Name | Start | Finish |
|---|---|---|
Practice Recruitment | April 1 2018 | November 30 2018 |
 ○ Publicity will be communicated through the PBRN newsletter and/or blog posts | ||
 ○ After publicity appears, all practices in the three PBRN’s will be sent a letter, information sheet and consent form. | ||
 ○ Practices expressing interest will receive a visit from investigators or a research staff team member to facilitate a more detailed discussion of the study. | ||
Practice Randomisation  ○ Dynamic randomisation of practices will occur after consent has been gained by practices. | ||
Data collection  ○ Distribution of pre-trial provider and facility surveys to practices | ||
 ○ A sample of consenting practice staff will be contacted directly by the research team to arrange qualitative interviews following randomisation | ||
Patient Recruitment | June 1 2018 | December 31 2018 |
 ○ A Practice Nurse in the consenting practices will run an electronic search of the patient database in order to identify potential participants who meet the inclusion criteria | ||
 ○ A sample of 200 patients identified in the electronic search will be sent an information pack containing a letter of invitation, an information sheet and a consent form.  ○ After 2 weeks, if recruitment is insufficient, then direct invitation to patients presenting to the practice will commence | ||
Baseline data collection  ○ Distribution of pre-trial patient surveys: PCAT, EQ-5D-5 L HRQOL and ease of access survey to parents/guardians of <16 patients. | ||
 ○ A sample of consenting patients will be contacted directly by the research team to arrange qualitative interviews following recruitment. | ||
Intervention period | August 1 2018 | July 31 2019 |
Intervention facilitation | ||
 ○ Intervention facilitators to visit intervention GP practices 3 times | August 1 2018 | January 31 2019 |
Follow-up data collection | July 1 2019 | August 31 2019 |
 ○ A sample of consenting practice staff will be contacted directly by the research team to arrange follow-up qualitative interviews. | ||
 ○ Distribution of post-trial patient surveys: PCAT, EQ-5D-5 L and ease of access survey to parents/guardians of <16 patients. | ||
 ○ A sample of consenting patients will be contacted directly by the research team to arrange qualitative interviews. | ||
 ○ Intervention facilitator interviews | ||
 ○ Electronic Health Record data extraction for period August 1 2017 – July 31 2019 |